Fonar Corporation (FONR) at a glance
Fonar Corporation (FONR) is a micro-cap Healthcare company. It trades at $19.09, with a P/E of 19.1, a 6.4% profit margin and revenue decline of 2.6%. It pays a 6% dividend yield. Vestovix scores it 57/100 overall. Its strongest dimension is Momentum (86/100) and its weakest is Growth (22/100). Its volatility is roughly in line with the market.
- Price
- $19.09
- Market cap
- $120.2M
- P/E ratio
- 19.1
- Dividend yield
- 5.97%
- Beta
- 0.95
- 52-week range
- $13.62 to $19.16
Value
68
Growth
22
Income
79
Safety
50
Momentum
86
Other Healthcare stocks
See allDHR.PR.A50
Danaher Corp
$1,841.01+0.00%
2.58% yield
LLY68
Eli Lilly and Company
$1,116.20-0.96%
0.57% yield
JNJ61
Johnson & Johnson
$266.20+0.73%
2.18% yield
ABBV46
AbbVie Inc.
$257.12-0.86%
2.96% yield
UNH56
UnitedHealth Group Incorporated
$378.73-0.34%
2.16% yield
MRK60
Merck & Co., Inc.
$144.01-0.98%
2.79% yield
ABT54
Abbott Laboratories
$103.57+0.92%
2.16% yield
AMGN65
Amgen Inc.
$378.21-1.05%
2.76% yield